M28 Capital Management LP 4
4 · Fractyl Health, Inc. · Filed Feb 8, 2024
Insider Transaction Report
Form 4
Elia Marc
Director
Transactions
- Conversion
Common Stock
2024-02-06+1,389,451→ 1,389,451 total(indirect: See footnotes) - Purchase
Common Stock
2024-02-06$15.00/sh+466,666$6,999,990→ 1,856,117 total(indirect: See footnotes) - Conversion
Series F Preferred Stock
2024-02-06−2,981,763→ 0 total(indirect: See footnotes)→ Common Stock (1,389,451 underlying)
Footnotes (3)
- [F1]In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock.
- [F2]This Form 4 is filed by M28 Capital Management LP ("M28 Capital Management") and Marc Elia ("Mr. Elia", and each of Mr. Elia and M28 Capital Management, a "Reporting Person"). The securities reported herein are held by certain funds and accounts for which M28 Capital Management serves as investment manager. Mr. Elia is the Chief Investment Officer of M28 Capital Management and the Managing Member of M28 Capital Management GP LLC, the general partner of M28 Capital Management. Mr. Elia also serves on the Board of Directors of the Issuer.
- [F3]Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any.